Assess whether to report a refusal for shy bladder (f7f624)

SITUATION A company transitioning to oral fluid cannot treat a dilute pattern in one shift at one terminal as incidental context on prescription that could explain an opioid positive. Medical review officer must close to report a refusal from that extract under Forensic Drug Testing / Program Design and Audit.

DECISION Medical review officer in a company transitioning to oral fluid must choose Accept the result / Reject on custody / Recollect / Hold using prescription that could explain an opioid positive after a dilute pattern in one shift at one terminal.

HYPOTHESES TO TEST 1. Authorize Accept the result now; prescription that could explain an opioid positive already has the discriminator after a dilute pattern in one shift at one terminal. 2. Keep Reject on custody in force until prescription that could explain an opioid positive is completed after a dilute pattern in one shift at one terminal for medical review officer. 3. Treat prescription that could explain an opioid positive as Recollect because both readings appear after a dilute pattern in one shift at one terminal. 4. Refuse a Forensic Drug Testing close: medical review officer does not have the decision to report a refusal turns on in prescription that could explain an opioid positive.

ANALYSIS REQUIRED 1. Confirm the kit ID in prescription that could explain an opioid positive matches the collection log. 2. Check MRO notes and cutoffs against the protocol a company transitioning to oral fluid claims to run. 3. Walk chain of custody, collection site, and validity flags in prescription that could explain an opioid positive after a dilute pattern in one shift at one terminal. 4. For this Forensic Drug Testing Program Design and Audit file, read prescription that could explain an opioid positive against a dilute pattern in one shift at one terminal and write the one fact that would move to report a refusal for medical review officer.

RECOMMENDATION Choose Accept the result / Reject on custody / Recollect / Hold on this Forensic Drug Testing / Program Design and Audit packet (prescription that could explain an opioid positive after a dilute pattern in one shift at one terminal). The follow-on Program Design and Audit action is what medical review officer does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line Forensic Drug Testing option on to report a refusal, then the evidence in prescription that could explain an opioid positive, then the action for medical review officer - Hypothesis scorecard against prescription that could explain an opioid positive: supported / rejected / untestable - Owner and next date for medical review officer in a company transitioning to oral fluid - What changes to report a refusal if a dilute pattern in one shift at one terminal is later withdrawn